Bluejay Diagnostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bluejay Diagnostics, Inc. (BJDX) on June 17, 2024. The report details the implementation of a reverse stock split approved by stockholders at the Annual Meeting held on May 14, 2024. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and capital structure changes.
Material Changes
- Reverse Stock Split: The Company implemented a 1-for-8 reverse stock split effective at 12:01 a.m. Eastern time on June 20, 2024.
- Share Count Reduction: Issued and outstanding common shares were reduced from 4,511,756 to approximately 563,969 shares.
- Trading Details: Post-split trading began on The Nasdaq Capital Market on June 20, 2024, under the existing symbol "BJDX" with a new CUSIP number (095633400).
- Equity Adjustments: Exercise prices and share counts for outstanding equity awards and warrants were adjusted proportionately. The number of shares authorized under the equity incentive plan was also reduced proportionately.
- Fractional Shares: No fractional shares were issued. Stockholders entitled to fractional shares received cash payments based on the average closing price over the ten trading days ending June 17, 2024.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the summary is qualified by reference to the attached Certificate of Amendment. The primary purpose of the filing is to notify the market of the completed capital structure change.
Investor Verification Checklist
- Verify the new CUSIP number (095633400) for post-split trading.
- Confirm the adjusted number of shares held in brokerage accounts or via the transfer agent (Continental Stock Transfer & Trust Company).
- Review the cash payment received for any fractional shares, calculated based on the average closing price ending June 17, 2024.
- Check the adjusted exercise prices and share quantities for any outstanding stock options or warrants.